dc.contributor.author |
Bustamante Rufino, Ana Beatriz |
|
dc.contributor.author |
Ahmed, Sarah-Abdalla |
|
dc.contributor.author |
De-Hoog, G. S. |
|
dc.contributor.author |
Seas Ramos, Carlos Rafael |
|
dc.contributor.author |
Van-De-Sande, Wendy-W. J. |
|
dc.date.accessioned |
2019-02-06T14:51:17Z |
|
dc.date.available |
2019-02-06T14:51:17Z |
|
dc.date.issued |
2016 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/5195 |
|
dc.description.abstract |
Eumycetoma is a chronic granulomatous fungal disease of the subcutaneous tissues characterized by large tumorous masses and the production either black or white grains. As a result of the use of molecular diagnostic techniques, previously unrecognized causative agents of eumycetoma have been discovered. We report the first case to our knowledge of eumycetoma caused by Phaeoacremonium sphinctrophorum... |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
American Medical Association |
|
dc.relation.ispartofseries |
JAMA Dermatology |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Adult |
en_US |
dc.subject |
Antifungal Agents/therapeutic use |
en_US |
dc.subject |
Ascomycota/isolation & purification |
en_US |
dc.subject |
Biopsy, Needle |
en_US |
dc.subject |
Follow-Up Studies |
en_US |
dc.subject |
Foot Dermatoses/drug therapy/microbiology/pathology |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Immunohistochemistry |
en_US |
dc.subject |
Itraconazole/therapeutic use |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Mycetoma/diagnosis/drug therapy/pathology |
en_US |
dc.subject |
Severity of Illness Index |
en_US |
dc.subject |
Treatment Outcome |
en_US |
dc.title |
Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1001/jamadermatol.2016.1310 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.15 |
|
dc.relation.issn |
2168-6084 |
|